Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines

Cohen, Justin D. ; Robins, H. Ian
Springer
Published 1990
ISSN:
1573-0646
Keywords:
diethyldithiocarbamate ; disulfiram ; cytotoxicity ; human ; cancer
Source:
Springer Online Journal Archives 1860-2000
Topics:
Chemistry and Pharmacology
Medicine
Notes:
Summary Diethyldithiocarbamate (DDTC) and other dithiocarbamates are currently receiving attention as potential adjuncts to traditional chemotherapy. In vitro studies with rodent cancer cell lines have consistently shown that DDTC concentrations of 0.1–1.0μ g/ml are highly cytotoxic. Paradoxically, however, concentrations of 10–100 μg/ml have been significantly less toxic. In the present study, such a ‘biphasic’ pattern was reproduced when 3 rodent cell lines were exposed for 1 hour to 0.001 to 1000 μg DDTC/ml. In contrast, in 7 human cell lines survival decreased steadily with increasing DDTC concentration (in the same dose range) without evidence of a biphasic pattern. These data might have implications for studies in which rodent cell lines are used to model the effects of dithiocarbamates in human tissues.
Type of Medium:
Electronic Resource
URL:
_version_ 1798297439265882112
autor Cohen, Justin D.
Robins, H. Ian
autorsonst Cohen, Justin D.
Robins, H. Ian
book_url http://dx.doi.org/10.1007/BF00177247
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLM197076580
issn 1573-0646
journal_name Investigational new drugs
materialart 1
notes Summary Diethyldithiocarbamate (DDTC) and other dithiocarbamates are currently receiving attention as potential adjuncts to traditional chemotherapy. In vitro studies with rodent cancer cell lines have consistently shown that DDTC concentrations of 0.1–1.0μ g/ml are highly cytotoxic. Paradoxically, however, concentrations of 10–100 μg/ml have been significantly less toxic. In the present study, such a ‘biphasic’ pattern was reproduced when 3 rodent cell lines were exposed for 1 hour to 0.001 to 1000 μg DDTC/ml. In contrast, in 7 human cell lines survival decreased steadily with increasing DDTC concentration (in the same dose range) without evidence of a biphasic pattern. These data might have implications for studies in which rodent cell lines are used to model the effects of dithiocarbamates in human tissues.
package_name Springer
publikationsjahr_anzeige 1990
publikationsjahr_facette 1990
publikationsjahr_intervall 8009:1990-1994
publikationsjahr_sort 1990
publisher Springer
reference 8 (1990), S. 137-142
schlagwort diethyldithiocarbamate
disulfiram
cytotoxicity
human
cancer
search_space articles
shingle_author_1 Cohen, Justin D.
Robins, H. Ian
shingle_author_2 Cohen, Justin D.
Robins, H. Ian
shingle_author_3 Cohen, Justin D.
Robins, H. Ian
shingle_author_4 Cohen, Justin D.
Robins, H. Ian
shingle_catch_all_1 Cohen, Justin D.
Robins, H. Ian
Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines
diethyldithiocarbamate
disulfiram
cytotoxicity
human
cancer
diethyldithiocarbamate
disulfiram
cytotoxicity
human
cancer
Summary Diethyldithiocarbamate (DDTC) and other dithiocarbamates are currently receiving attention as potential adjuncts to traditional chemotherapy. In vitro studies with rodent cancer cell lines have consistently shown that DDTC concentrations of 0.1–1.0μ g/ml are highly cytotoxic. Paradoxically, however, concentrations of 10–100 μg/ml have been significantly less toxic. In the present study, such a ‘biphasic’ pattern was reproduced when 3 rodent cell lines were exposed for 1 hour to 0.001 to 1000 μg DDTC/ml. In contrast, in 7 human cell lines survival decreased steadily with increasing DDTC concentration (in the same dose range) without evidence of a biphasic pattern. These data might have implications for studies in which rodent cell lines are used to model the effects of dithiocarbamates in human tissues.
1573-0646
15730646
Springer
shingle_catch_all_2 Cohen, Justin D.
Robins, H. Ian
Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines
diethyldithiocarbamate
disulfiram
cytotoxicity
human
cancer
diethyldithiocarbamate
disulfiram
cytotoxicity
human
cancer
Summary Diethyldithiocarbamate (DDTC) and other dithiocarbamates are currently receiving attention as potential adjuncts to traditional chemotherapy. In vitro studies with rodent cancer cell lines have consistently shown that DDTC concentrations of 0.1–1.0μ g/ml are highly cytotoxic. Paradoxically, however, concentrations of 10–100 μg/ml have been significantly less toxic. In the present study, such a ‘biphasic’ pattern was reproduced when 3 rodent cell lines were exposed for 1 hour to 0.001 to 1000 μg DDTC/ml. In contrast, in 7 human cell lines survival decreased steadily with increasing DDTC concentration (in the same dose range) without evidence of a biphasic pattern. These data might have implications for studies in which rodent cell lines are used to model the effects of dithiocarbamates in human tissues.
1573-0646
15730646
Springer
shingle_catch_all_3 Cohen, Justin D.
Robins, H. Ian
Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines
diethyldithiocarbamate
disulfiram
cytotoxicity
human
cancer
diethyldithiocarbamate
disulfiram
cytotoxicity
human
cancer
Summary Diethyldithiocarbamate (DDTC) and other dithiocarbamates are currently receiving attention as potential adjuncts to traditional chemotherapy. In vitro studies with rodent cancer cell lines have consistently shown that DDTC concentrations of 0.1–1.0μ g/ml are highly cytotoxic. Paradoxically, however, concentrations of 10–100 μg/ml have been significantly less toxic. In the present study, such a ‘biphasic’ pattern was reproduced when 3 rodent cell lines were exposed for 1 hour to 0.001 to 1000 μg DDTC/ml. In contrast, in 7 human cell lines survival decreased steadily with increasing DDTC concentration (in the same dose range) without evidence of a biphasic pattern. These data might have implications for studies in which rodent cell lines are used to model the effects of dithiocarbamates in human tissues.
1573-0646
15730646
Springer
shingle_catch_all_4 Cohen, Justin D.
Robins, H. Ian
Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines
diethyldithiocarbamate
disulfiram
cytotoxicity
human
cancer
diethyldithiocarbamate
disulfiram
cytotoxicity
human
cancer
Summary Diethyldithiocarbamate (DDTC) and other dithiocarbamates are currently receiving attention as potential adjuncts to traditional chemotherapy. In vitro studies with rodent cancer cell lines have consistently shown that DDTC concentrations of 0.1–1.0μ g/ml are highly cytotoxic. Paradoxically, however, concentrations of 10–100 μg/ml have been significantly less toxic. In the present study, such a ‘biphasic’ pattern was reproduced when 3 rodent cell lines were exposed for 1 hour to 0.001 to 1000 μg DDTC/ml. In contrast, in 7 human cell lines survival decreased steadily with increasing DDTC concentration (in the same dose range) without evidence of a biphasic pattern. These data might have implications for studies in which rodent cell lines are used to model the effects of dithiocarbamates in human tissues.
1573-0646
15730646
Springer
shingle_title_1 Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines
shingle_title_2 Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines
shingle_title_3 Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines
shingle_title_4 Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Springer Online Journal Archives 1860-2000
timestamp 2024-05-06T10:08:00.924Z
titel Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines
titel_suche Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines
topic V
WW-YZ
uid nat_lic_papers_NLM197076580